HELLO JOE ,
What I want to khnow the percentage of the women HER2 - positivity who had been exposed to one year of Herceptin not 2 years of Herceptin in adjuvant treatment and developped reccurence after ?
From HERA study The break down of risk for relaspe is as follows for observation group after 2 years follow up .
ER,PR Negative, her2+
Node Negative 18%
1-3 nodes 25%
greater 4 nodes 33%
ER,PR positive, her2+
Node Negative 9%
1-3 Nodes 12%
greater 4 nodes 33%
but I d'ont find anyting for the group one year herceptin .
I look forward to your prompt reply ,
Thank you for your cooperation ..
Sincerely,
VIVIANE
|